- $276.72m
- $231.85m
- $123.59m
NYSE ORDER IMBALANCE 93775.0 SHARES ON BUY SIDE
NYSE ORDER IMBALANCE 1293384.0 SHARES ON BUY SIDE
U.S. RESEARCH ROUNDUP- Aptinyx, Rapid Micro Biosystems, Trinet Group
Brief: Blend Labs Committed To Second Workforce Reduction Plan
Blend Labs Inc reports results for the quarter ended in June - Earnings Summary
Brief: Blend Announces Q2 2022 Financial Results
NYSE ORDER IMBALANCE 58482.0 SHARES ON BUY SIDE
Blend Labs Inc expected to post a loss of 19 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Grove Collaborative Holdings, Annovis Bio, Kellogg Co
Keybanc downgrades Blend Labs on inflationary headwinds
NYSE ORDER IMBALANCE 499792.0 SHARES ON BUY SIDE
NYSE ORDER IMBALANCE 154023.0 SHARES ON BUY SIDE
NYSE ORDER IMBALANCE 164527.0 SHARES ON BUY SIDE
NYSE ORDER IMBALANCE 114024.0 SHARES ON BUY SIDE
NYSE ORDER IMBALANCE 70668.0 SHARES ON BUY SIDE
NYSE ORDER IMBALANCE 65491.0 SHARES ON SELL SIDE
NYSE ORDER IMBALANCE 80007.0 SHARES ON BUY SIDE
NYSE ORDER IMBALANCE 62145.0 SHARES ON BUY SIDE
NYSE ORDER IMBALANCE 99135.0 SHARES ON BUY SIDE